The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol have published the EU Drug Markets Analysis: Key insights for policy and practice report. This resource has been developed by the EMCDDA and Europol and co-produced with the EMCDDA Reference Group on Drug Supply Indicators.
It draws on the detailed findings presented in EU Drug Markets: In-depth analysis, the fourth comprehensive overview of illicit drug markets in the European Union. It offers a strategic and top-level summary for policymakers and decision-makers, to support the development and implementation of policies and actions in Europe, based on a robust understanding of the current drug landscape and emerging threats. It also serves practitioners working in the field and is intended to raise awareness among the general public about these issues.
The report is available following this link>>>.